Expression Systems Search Results


96
TaKaRa plvx ires neo lentiviral vector
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Plvx Ires Neo Lentiviral Vector, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Lenti-X+Bicistronic+Expression+System/10__1091_slash_mbc__e16___01___0048-208-17-20
Average 96 stars, based on 1 article reviews
plvx ires neo lentiviral vector - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
R&D Systems tnfα
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Tnfα, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+TNF-alpha+(HEK293-expressed)+Protein%2C+CF/pm36639926-34-16-17
Average 95 stars, based on 1 article reviews
tnfα - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
R&D Systems mouse il
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Mouse Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Mouse+IL-27+(NS0-expressed)+Protein/pm25888222-46-2-29
Average 93 stars, based on 1 article reviews
mouse il - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems recombinant human oncostatin m
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Recombinant Human Oncostatin M, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+Oncostatin+M+(HEK-293-expressed)+Protein/pm41932341-856-40-46
Average 94 stars, based on 1 article reviews
recombinant human oncostatin m - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems rhtpo
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Rhtpo, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+Thrombopoietin+(NS0-expressed)+Protein/pm38062131-245-21-25
Average 94 stars, based on 1 article reviews
rhtpo - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
R&D Systems factor kappa b ligand
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Factor Kappa B Ligand, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Mouse+TRANCE%2FRANK+L%2FTNFSF11+(E%2E+coli-expressed)/pm41762453-93-36-40
Average 96 stars, based on 1 article reviews
factor kappa b ligand - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
R&D Systems factor m csf
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Factor M Csf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+M-CSF+(CHO-expressed)+Protein/bio_rxiv__64898__2026__02__12__705496-152-29-32
Average 94 stars, based on 1 article reviews
factor m csf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
R&D Systems tgfβ3
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Tgfβ3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+TGF-beta+3+(CHO-expressed)+Protein/pm40074890-573-25-29
Average 95 stars, based on 1 article reviews
tgfβ3 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
R&D Systems positive control
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Positive Control, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+CD40+Ligand%2FTNFSF5+(HEK293-expressed)/pmc12852821-440-2-6
Average 94 stars, based on 1 article reviews
positive control - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
R&D Systems tgf β1
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Tgf β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+TGF-beta+1+(Human+Cell-expressed)+Protein/pm35090322-59-0-4
Average 96 stars, based on 1 article reviews
tgf β1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
R&D Systems tgf β
FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo <t>lentiviral</t> vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for
Tgf β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+TGF-beta+1+(Human+Cell-expressed)%2C+CF/10__3390_slash_molecules24183360-153-21-26
Average 95 stars, based on 1 article reviews
tgf β - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
R&D Systems recombinant human hgf
Experiment summary. (A) Experiment 1 included the liver resection model. The 30% (0%), 30% (7%), and 40% (10%) models were created by liver resection and vein ligation. Gray color within the liver represents the congested area. (B) Experiment 2 included the liver transplantation model. The livers from the 30% (0%), 30% (7%), 40% (10%), 50% (7%), and 60% (10%) models were used as grafts for experiment 2. These grafts were chilled at 4°C for 1 hour in HTK solution and transplanted into syngeneic rats. (C) Experiment 3 included the liver transplantation plus <t>HGF</t> administration model. Rats in the 50% (7%) liver transplantation model received 100 µg/kg <t>recombinant</t> human HGF administered through the penile vein under anesthesia immediately after surgery and on POD1 and POD2. Abbreviations: HTK, histidine-tryptophan-ketoglutarate; i.v., intravenous injection; LHV, left hepatic vein; LML, left median lobe; POD, postoperative day; RHV, right hepatic vein; RML, right median lobe.
Recombinant Human Hgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Expression+Systems/Recombinant+Human+HGF+(NS0-expressed)+Protein/pmc11643138-45-6-14
Average 93 stars, based on 1 article reviews
recombinant human hgf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo lentiviral vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for

Journal: Molecular Biology of the Cell

Article Title: Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation

doi: 10.1091/mbc.e16-01-0048

Figure Lengend Snippet: FIGURE 5: Inhibition of EphA2-dependent cell retraction by cAMP requires S897 phosphorylation. (A) Representative images of phalloidin-labeled EphA2 knockdown PC3 cell populations infected with pLVX-IRES-Neo lentiviral vector (Vector) or lentivirus encoding WT EphA2 (WT) or the indicated EphA2 mutants. The cells, pretreated or not for

Article Snippet: The pLVX lentivirus encoding FLAG-tagged EphA2 WT was obtained by replacing the NdeI-BamHI restriction fragment of the pLVX-IRES-Neo lentiviral vector (#632181;Takara Clontech) with the corresponding fragment from the pFLAG-CMV3 plasmid (E6783; Sigma-Aldrich), which encodes a signal peptide followed by the FLAG tag sequence, and then cloning the human EphA2 mature coding sequence (nucleotides 175- 3061; GenBank accession number BC037166) using the NotI site in the EphA2 sequence and a restriction site in the lentivirus multiple cloning site.

Techniques: Inhibition, Phospho-proteomics, Labeling, Knockdown, Infection, Plasmid Preparation

Experiment summary. (A) Experiment 1 included the liver resection model. The 30% (0%), 30% (7%), and 40% (10%) models were created by liver resection and vein ligation. Gray color within the liver represents the congested area. (B) Experiment 2 included the liver transplantation model. The livers from the 30% (0%), 30% (7%), 40% (10%), 50% (7%), and 60% (10%) models were used as grafts for experiment 2. These grafts were chilled at 4°C for 1 hour in HTK solution and transplanted into syngeneic rats. (C) Experiment 3 included the liver transplantation plus HGF administration model. Rats in the 50% (7%) liver transplantation model received 100 µg/kg recombinant human HGF administered through the penile vein under anesthesia immediately after surgery and on POD1 and POD2. Abbreviations: HTK, histidine-tryptophan-ketoglutarate; i.v., intravenous injection; LHV, left hepatic vein; LML, left median lobe; POD, postoperative day; RHV, right hepatic vein; RML, right median lobe.

Journal: Liver Transplantation

Article Title: Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats

doi: 10.1097/LVT.0000000000000449

Figure Lengend Snippet: Experiment summary. (A) Experiment 1 included the liver resection model. The 30% (0%), 30% (7%), and 40% (10%) models were created by liver resection and vein ligation. Gray color within the liver represents the congested area. (B) Experiment 2 included the liver transplantation model. The livers from the 30% (0%), 30% (7%), 40% (10%), 50% (7%), and 60% (10%) models were used as grafts for experiment 2. These grafts were chilled at 4°C for 1 hour in HTK solution and transplanted into syngeneic rats. (C) Experiment 3 included the liver transplantation plus HGF administration model. Rats in the 50% (7%) liver transplantation model received 100 µg/kg recombinant human HGF administered through the penile vein under anesthesia immediately after surgery and on POD1 and POD2. Abbreviations: HTK, histidine-tryptophan-ketoglutarate; i.v., intravenous injection; LHV, left hepatic vein; LML, left median lobe; POD, postoperative day; RHV, right hepatic vein; RML, right median lobe.

Article Snippet: The 50% (7%) model rats received recombinant human HGF (50 μg/mL; catalog number 294-HGN; R&D Systems) administered at 100 μg/kg through the penile vein under anesthesia immediately after LT and on PODs 1 and 2 (Figure C).

Techniques: Ligation, Transplantation Assay, Recombinant, Injection